ID 401963416 · FY 2018–2023 · 6 years
Sando Pharm (სანდო ფარმა) — a Tbilisi-based pharmaceutical wholesaler / distribution base engaged in wholesale trade of pharmaceutical goods (part of the Sando Group, which also runs the sando.com.ge medicine-comparison platform). Thin distribution margins (~8–15%); revenue declining toward 2023.
curated 2026-06-25
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|---|---|
| Total Revenue | 4,272 | 4,761 | 5,363 | 5,621 | 4,936 | 1,341 | -20.7% |
| Total COGS | -3,798 | -4,361 | -4,790 | -5,045 | -4,197 | -1,209 | -20.5% |
| Gross Profit | 473 | 400 | 573 | 576 | 739 | 132 | -22.6% |
| Gross Margin | 11.1% | 8.4% | 10.7% | 10.3% | 15.0% | 9.8% | |
| Total Operating Expenses | -482 | -484 | -522 | -781 | -842 | -501 | +0.8% |
| EBITDA | -8 | -84 | 51 | -204 | -103 | -369 | +113.0% |
| EBITDA Margin | -0.2% | -1.8% | 1.0% | -3.6% | -2.1% | -27.5% | |
| Total D&A | -9 | -11 | -15 | -15 | -35 | -43 | +35.7% |
| EBIT / Operating Income | -18 | -95 | 36 | -219 | -138 | -412 | +87.4% |
| Total Interest Expense | -11 | -13 | -10 | -21 | -30 | -38 | +27.8% |
| Total Other Income | 0 | 0 | 112 | 53 | 125 | 20 | -43.9% |
| Profit Before Tax | -29 | -108 | 138 | -186 | -43 | -431 | +71.5% |
| Total Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Profit / (Loss) | -8 | -84 | 51 | -204 | -103 | -369 | +113.0% |
| Net Margin | -0.2% | -1.8% | 1.0% | -3.6% | -2.1% | -27.5% |
Ownership & directors from companyinfo.ge (public corporate registry).